对具有超长CDRs的抗体的药物开发性观点
Marcel Passon1, Stefaan De Smedt1, Hristo L Svilenov2
1Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium.
Journal of pharmaceutical sciences
|December 25, 2025
概括
具有超长互补性决定区域 (ulCDRs) 的抗体对药物开发具有有希望的稳定性. 它们独特的ULCDRs影响着体性质,影响抗体开发能力和自我结合.
科学领域:
- 生物化学 生化学
- 免疫学 免疫学 免疫学
- 制药科学 制药科学
背景情况:
- 具有超长互补性确定区域 (ulCDRs) 的抗体具有独特的抗原结合能力.
- UlCDRs的制药潜力是显著的,但它们的稳定性和可开发性尚未得到充分理解.
研究的目的:
- 系统地分析含有ulCDRs的Fab碎片的物理和合稳定性.
- 评估ulCDR Fabs作为潜在的治疗抗体候选人.
主要方法:
- 使用光和光散射测试来评估pH范围内的热和体稳定性.
- 进行了应力和储存研究,以评估在机械和热挑战下的稳定性.
- 测量相对溶解度以评估合物性质.
主要成果:
- ulCDR Fab碎片显示出良好的热稳定性和最小的聚合.
- 确定ULCDRs是弱自我关联的关键决定因素,影响着体稳定性.
- ulCDR Fabs在机械应力和高温下保持了高稳定性.
结论:
- ulCDR Fabs对治疗应用具有有利的整体物理稳定性.
- 由ulCDRs驱动的弱自我相互作用是区分这种类别内的抗体特性的关键因素.
相关概念视频
Antibody Structure
65.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.2K
Antibody Structure and Classes
8.1K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
8.1K
Hybridoma Technology
17.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K
Diversity of Antigen Receptors
1.3K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.3K


